Loading
SPEC
Menu
  • Home
  • Physician Education Center
    • Enduring Programs
      • Acute Heart Failure
      • Alzheimer’s Disease
      • COPD
      • Multiple Sclerosis
      • Oncology Pathways
      • PD-1 Inhibition
      • Prostate Cancer
      • Rheumatology
      • Schizophrenia
    • Close
  • Pharma Education Center
    • Enduring Clinical Programs
      • Acute Heart Failure
      • Alzheimer’s Disease
      • Ankylosing Spondylitis
      • Asthma
      • Chronic Kidney Disease
      • COPD
      • Crohn’s Disease
      • Epilepsy
      • Familial Hypercholesterolemia
      • Hemophilia
      • Hepatitis
      • HIV/AIDS
      • Immunoglobulins
      • Multiple Sclerosis
      • Pulmonary Arterial Hypertension
      • Rheumatoid Arthritis
      • Schizophrenia
      • Transplantation
    • Enduring Oncology Programs
      • Acute Lymphoblastic Leukemia
      • Acute Myeloid Leukemia
      • Glioblastoma Multiforme
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Multiple Myeloma
      • Oncology Pathways
      • Oral Oncolytics
      • PD-1 Inhibition
      • Prostate Cancer
      • Renal Cell Carcinoma
    • Close
  • About SPEC
    • Get Involved
    • Accreditations
    • Terms of Use
    • Close
  • My Learning Activities
  • Login/Register
March 20, 2015/by Karim Bandealy

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Linkedin
  • Share by Mail
http://www.specialtycme.org/wp-content/uploads/2015/02/SPEC_Main_Logo_01_FINAL_KB-300x71.png 0 0 Karim Bandealy http://www.specialtycme.org/wp-content/uploads/2015/02/SPEC_Main_Logo_01_FINAL_KB-300x71.png Karim Bandealy2015-03-20 16:17:472015-03-20 16:17:57

Navigate To…

  • Specialty Physician Education Center
  • Specialty Pharma Education Center
  • Specialty Patient Education Center
  • Get Involved
  • About SPEC
  • FAQs

Recent Posts

  • FDA Approves Amgen’s PCSK9 Drug Repatha
  • Amgen Files for FDA Approval of its Secondary Hyperparathyroidism Drug
  • First Patient Enrolled in CSL Behring’s On-Demand Treatment for Patients with Hemophilia A or B with Inhibitors
  • Banner MD Anderson to Test New Drug for Late-Stage Pancreatic Cancer
  • Eighty Percent of Physicians Want More Education on Biosimilars

Archives

  • August 2015
  • July 2015
  • June 2015
  • January 2015

Upcoming Events

  • No events

Sign Up for our Monthly Newsletter!

Latest Published CME/CPE/CNE

An Overview of Pulmonary Arterial Hypertension (PAH): Update on Clinical Considerations & Diagnosis

Ankylosing Spondylitis: An Update on Clinical Considerations, Diagnosis and Treatment Options

Individualized Treatment Plans in ALL: Effective Management Strategies to Optimize Patient Outcomes

The Growing Threat of HPV-Positive Head and Neck Cancer

RA: Prevention and Management of Toxicities Associated with Disease Modifying Therapies

Upcoming Events

  • No events

Contact Us

Specialty Pharma Education Center
 703.229.6260
 info@specialtycme.org

© Copyright 2018 - Specialty Pharma Education Center. All Rights Reserved.

Scroll to top